immatics.asia immatics.asia

immatics.asia

immatics biotechnologies - active against cancer

immatics is a private biopharmaceutical company based in Tuebingen, Germany. We are focused on the discovery and development of innovative active immunotherapies against cancer. Our proprietary technology allows us to identify tumor-associated peptides (TUMAPs) that are associated with particular cancers.

http://www.immatics.asia/

TRAFFIC RANK FOR IMMATICS.ASIA

TODAY'S RATING

> 1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

CUSTOMER REVIEWS

Average Rating: 4.2 out of 5 with 5 reviews
5 star
3
4 star
0
3 star
2
2 star
0
1 star
0

Hey there! Start your review of immatics.asia

AVERAGE USER RATING

Write a Review

CONTACTS AT IMMATICS.ASIA

immatics biotechnologies

Emmerich Niels

Paul-E●●●●●●tr. 15

Tue●●●gen , Germany, 72076

DE

49.7●●●●1250
it@immatics.com

View this contact

Cronon AG IT-Services

Strato Rechenzentrum Hostmaster

Emmy-N●●●●●●tr. 10

Kar●●●uhe , Germany, D-76131

DE

49.7●●●●0307
49.7●●●●0303
ho●●●●●●●●@cronon-isp.net

View this contact

iTECS Communications Pvt. Ltd.

Kurian Devasia

16th B●●●●●●. 2450

HAL II S●●●●●●●●iranagar

Ban●●●ore , Karnataka, 560008

IN

91.9●●●●3665
do●●●●●@itecscom.com

View this contact

Create Account

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2008 March 27
UPDATED
n/a
EXPIRATION
n/a

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 13

    YEARS

  • 2

    MONTHS

  • 27

    DAYS

NAME SERVERS

1
docks16.rzone.de

CONTENT

SCORE

6.2

SCREENSHOTS
Preview of immatics.asia Tablet Preview of immatics.asia Mobile Preview of immatics.asia
FAVICONS
    PAGE TITLE
    immatics biotechnologies - active against cancer | immatics.asia contacts
    <META>
    DESCRIPTION
    immatics is a private biopharmaceutical company based in Tuebingen, Germany. We are focused on the discovery and development of innovative active immunotherapies against cancer. Our proprietary technology allows us to identify tumor-associated peptides (TUMAPs) that are associated with particular cancers.
    <META>
    KEYWORDS
    11 Tumor-specific antigen
    12 tumor peptidome
    13 cancer peptidome
    14 TUMAP
    15 tumor-associated peptides
    16 cancer-associated peptides
    17 xpresident
    18
    19
    20 coupons
    CONTENT
    We aim to achieve this by using multiple and relevant peptides that specifically activate T cells, specialized white blood cells, of the patients immune system against cancer cells. Our technology can also lead towards the development of novel immunotherapies based on antibodies and T-cell receptors. The Cancer Prevention and Research Institute of Texas CPRIT has awarded a grant of 19.7m to immatics biotechnologies . read more. Renal cell cancer phase 3 clinical trial. Phase 1 clinical trials. Walter.
    INTERNAL LINKS
    OTHER SITES
    SERVER
    Apache/2.4.29
    POWERED BY
    PHP/7.0.24
    CONTENT-TYPE
    iso-8859-1
    GOOGLE PREVIEW

    immatics biotechnologies - active against cancer

    https://immatics.asia

    immatics is a private biopharmaceutical company based in Tuebingen, Germany. We are focused on the discovery and development of innovative active immunotherapies against cancer. Our proprietary technology allows us to identify tumor-associated peptides (TUMAPs) that are associated with particular cancers.

    TOTAL PAGES IN THIS WEBSITE

    0